|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 7/09/03 Amgen Inc SC 13D/A 7/08/03 2:44K Tularik Inc RR Donnelley/FA |
Document/Exhibit Description Pages Size 1: SC 13D/A Amendment No.2 to Schedule 13D HTML 36K 2: EX-6 Letter Dated: July 7, 2003 HTML 7K
| Letter Dated: July 7, 2003 |
EXHIBIT 6
Tularik Inc.
Two Corporate Drive
Attn: William J. Rieflin
Dear Mr. Rieflin:
In connection with the sale of 3,000,000 shares of common stock (the “Shares”) of Tularik Inc. (the “Company”) from ZKB PharmaVision AG to Amgen Inc. (“Amgen” together with the Company, the “Parties”), which closed on the date hereof, the Parties agree that promptly upon receipt of the Shares, Amgen will transfer the Shares to the Company’s transfer agent, Wells Fargo Shareowner Services (the “Transfer Agent”), for proper certification in the form of a single stock certificate (the “Certificate”). The Company agrees to instruct the Transfer Agent to promptly perform the certification of the Shares and to transfer the Certificate to Amgen.
Amgen and the Company agree that until the Shares are reissued in the form of the Certificate, Amgen will not sell, convey or transfer any of the Shares without the written consent of the Company.
AMGEN INC.
By /s/ Steven M. Odre
Name: Steven M. Odre
Title: Senior Vice President, General
Counsel and Secretary
Agreed to and Accepted:
TULARIK INC.
/s/ William J. Rieflin
Name: William J. Rieflin
Title: Executive Vice President, Administration
| This ‘SC 13D/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 7/9/03 | 4 | ||
| Filed on: | 7/8/03 | 4, SC 13D/A | ||
| List all Filings | ||||